Komori
Olympus (7733) · InitiativeFirst stated

Global Optimization of Therapeutic Device Manufacturing Sites

First written in FY2021-Q2. . Latest entry: FY2021-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Optimization of the manufacturing structure through the transfer of the U.S. Norwalk therapeutic-device plantA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q2First statedAnnual report

    「Under an agreement with NISSHA announced on 6 August 2020, the Company completed on 2 November 2020 the transfer of the Norwalk plant, one of the US therapeutic device manufacturing sites of Olympus Surgical Technologies America, to NMT, a wholly owned subsidiary of NISSHA.」

    As part of Transform Olympus, the Company transferred its US Norwalk plant, which manufactures devices for urology and gynecology, among other products, to Nissha Medical Technologies and proceeded with optimizing its manufacturing structure.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Global Optimization of Therapeutic Device Manufacturing Sites | OLYMPUS CORPORATION (7733) | Komori